APA-referens (7:e uppl.)

Tsareva, N. A., & Avdeev, S. N. (2016). Riociguat is a novel medication for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Медицинский совет, 4, 20-27. https://doi.org/10.21518/2079-701X-2016-4-20-27

Chicago-referens (17:e uppl.)

Tsareva, N. A., och S. N. Avdeev. "Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension." Медицинский совет 4 (2016): 20-27. https://doi.org/10.21518/2079-701X-2016-4-20-27.

MLA-referens (9:e uppl.)

Tsareva, N. A., och S. N. Avdeev. "Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension." Медицинский совет, 4, 2016, pp. 20-27, https://doi.org/10.21518/2079-701X-2016-4-20-27.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.